Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa.

Bioassay-guided fractionation of a CH2Cl2/MeOH extract of the sponge Suberea clavata using the serine protease factor XIa to detect antithrombotic activity led to the isolation of the new marine natural products, clavatadines A and B. Clavatadines A and B inhibited factor XIa with IC50's of 1.3 and 27 microM, respectively. A crystal structure of protein-inhibitor (clavatadine A) complex was obtained and revealed interesting selective binding and irreversible inhibition of factor XIa. The cocrystal structure provides guidance for the design and synthesis of future factor XIa inhibitors as antithrombotic agents.

[1]  I. Piña,et al.  The structures of aplysinamisines I, II, and III; new bromotyrosine-derived alkaloids from the Caribbean sponge Aplysina cauliformis. , 1993, Journal of natural products.

[2]  M. Tsuda,et al.  Lipopurealins D and E and Purealidin H, New Bromotyrosine Alkaloids from the Okinawan Marine Sponge Psammaplysilla purea , 1995 .

[3]  Heonjoong Kang,et al.  Aplidiamine, a Unique Zwitterionic Benzyl Hydroxyadenine from the Western Australian Marine Ascidian Aplidiopsis sp. , 1997 .

[4]  Jongheon Shin,et al.  Euplexides A-E: Novel Farnesylhydroquinone Glycosides from the Gorgonian Euplexaura anastomosans. , 1999, The Journal of organic chemistry.

[5]  A. Carroll,et al.  Dysinosin A: a novel inhibitor of Factor VIIa and thrombin from a new genus and species of Australian sponge of the family Dysideidae. , 2002, Journal of the American Chemical Society.

[6]  R. Karlsson,et al.  A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry. , 2002, Analytical biochemistry.

[7]  A. Carroll,et al.  Dysinosins B-D, inhibitors of factor VIIa and thrombin from the Australian sponge Lamellodysidea chlorea. , 2004, Journal of natural products.

[8]  R. Babine,et al.  Mutation of surface residues to promote crystallization of activated factor XI as a complex with benzamidine: an essential step for the iterative structure-based design of factor XI inhibitors. , 2005, Acta crystallographica. Section D, Biological crystallography.

[9]  S. Goto.  Factor XIa as a possible new target of antithrombotic therapy , 2006, Journal of thrombosis and haemostasis : JTH.

[10]  R. Babine,et al.  Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an alpha-ketothiazole arginine. , 2006, Bioorganic & medicinal chemistry letters.

[11]  R. Babine,et al.  Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants. , 2006, Journal of medicinal chemistry.